USPTO serial 79359202
Serial No. 79359202
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 9, 2024
- Examiner
- BLOHM, LINDA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79359202?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes | ACTIVE | — |
| 042 | Testing, inspection and research of pharmaceuticals and consultancy relating thereto; research and development of pharmaceuticals and medical supplies; clinical trials; medical research; biological research; providing information relating to research of medicine; providing information relating to testing, inspection or research of medical services using of stem cells; providing information relating to research and development of pharmaceutical preparations; pharmaceutical drug development services; culturing of cells for scientific research purposes; testing, inspection or research of medical treatment methods and techniques; testing, inspection or research of cosmetics or foodstuffs; scientific research in the field of genetic engineering; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research services; research and development services in the field of gene expression systems; testing, inspection or research of regenerative medicine services; testing, inspection or research in the field of cells; culturing of cells for others for scientific research purposes; genetic testing of cells for research purposes; culturing cells for transplantation collected from patients themselves; providing quality assurance services in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; quality assurance consultancy services in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; quality control of goods and services of others; consultancy services relating to quality control of goods and services of others | ACTIVE | — |
| 044 | Providing medical information; medical and veterinary information services provided via the Internet; providing information to patients in the field of administering medication; medical care and analysis services relating to patient treatment; health clinic services; collection, analysis, and provision of information relating to medical care; treatment or diagnosis using regenerative medicine services; treatment or diagnosis using cell medicine services; dietary and nutritional guidance; animal breeding; veterinary services; rental of medical apparatus and instruments; providing medical or pharmaceutical consultancy and information services relating to biopharmaceutical products; cultured cell bank services for medical transplantation; medical treatment using cultured cells; stem cell bank services; stem cell therapy services; providing medical information in the field of cells; providing medical information in the field of regenerative medicine services; collection and preservation of biological tissues, blood and cells; treatment and diagnosis performed by culturing medical or clinical cells; medical services; providing information and data for diagnosis and medical treatment; medical treatment with cell preparations; medical professional consulting services; preservation of human blood for use as a source of stem cells; genetic testing for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health center services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 29, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 29, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 17, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 31, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 31, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 19, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 9, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 19, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 16, 2024 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 3, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 2, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 26, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 6, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 5, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 30, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |